Literature DB >> 25496434

Predictors of anxiety in multiple sclerosis.

Narineh Hartoonian1, Alexandra L Terrill2, Meghan L Beier2, Aaron P Turner1, Melissa A Day3, Kevin N Alschuler4.   

Abstract

PURPOSE/
OBJECTIVES: The aims of this study were to (1) identify the predictors of symptoms of anxiety, and (2) evaluate the differential association of somatic and nonsomatic symptoms of depression on anxiety over time in persons with multiple sclerosis (MS). METHOD/
DESIGN: Participants were 513 persons with MS who previously enrolled in a study exploring the experience of living with MS and completed a 4-month follow-up survey. The main outcome measure used was the Hospital Anxiety and Depression Scale-Anxiety. Demographic, disease-associated variables (time since onset of MS, Expanded Disability Status Scale Mobility, pain, and fatigue), and Time 1 psychological variables were entered into a hierarchical regression model to examine predictors at baseline for anxiety symptoms at Time 2.
RESULTS: A large portion of the sample was White (92%), female (82%), and had relapsing-remitting MS (57%). After adjusting for demographic and disease related variables, anxiety (β <.001), employment (β = .07), and nonsomatic depressive symptoms (β = .10) at baseline significantly predicted anxiety at Time 2, ps < .05. Interactions revealed significant effects for time since onset of MS and somatic symptoms as well as time since onset and nonsomatic symptoms, ps < .05. Nonsomatic symptoms were more linked to anxiety early in the disease and somatic symptoms were more prominently linked to anxiety later in the disease.
CONCLUSIONS: Findings suggest that nonsomatic symptoms of depression and employment predict anxiety in MS. The relationship between different aspects of depression and anxiety may change over the course of the disease. PsycINFO Database Record (c) 2015 APA, all rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25496434      PMCID: PMC4339307          DOI: 10.1037/rep0000019

Source DB:  PubMed          Journal:  Rehabil Psychol        ISSN: 0090-5550


  34 in total

1.  Positive and negative affectivity and their relation to anxiety and depressive disorders.

Authors:  D Watson; L A Clark; G Carey
Journal:  J Abnorm Psychol       Date:  1988-08

2.  Severity of chronic pain and its relationship to quality of life in multiple sclerosis.

Authors:  Lorraine V Kalia; Paul W O'Connor
Journal:  Mult Scler       Date:  2005-06       Impact factor: 6.312

Review 3.  Negative affectivity: the disposition to experience aversive emotional states.

Authors:  D Watson; L A Clark
Journal:  Psychol Bull       Date:  1984-11       Impact factor: 17.737

4.  Prediction of anxiety and distress following diagnosis of multiple sclerosis: a two-year longitudinal study.

Authors:  A C J W Janssens; D Buljevac; P A van Doorn; F G A van der Meché; C H Polman; J Passchier; R Q Hintzen
Journal:  Mult Scler       Date:  2006-12       Impact factor: 6.312

5.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.

Authors:  L B Krupp; N G LaRocca; J Muir-Nash; A D Steinberg
Journal:  Arch Neurol       Date:  1989-10

6.  The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis.

Authors:  A Feinstein; P O'Connor; T Gray; K Feinstein
Journal:  Mult Scler       Date:  1999-10       Impact factor: 6.312

7.  Prevalence and correlates of depression among veterans with multiple sclerosis.

Authors:  R M Williams; A P Turner; M Hatzakis; J D Bowen; A A Rodriquez; J K Haselkorn
Journal:  Neurology       Date:  2005-01-11       Impact factor: 9.910

8.  The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism.

Authors:  K S Kendler; E E Walters; M C Neale; R C Kessler; A C Heath; L J Eaves
Journal:  Arch Gen Psychiatry       Date:  1995-05

9.  Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis.

Authors:  R H B Benedict; I Fishman; M M McClellan; R Bakshi; B Weinstock-Guttman
Journal:  Mult Scler       Date:  2003-08       Impact factor: 6.312

10.  Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners.

Authors:  A C J W Janssens; P A van Doorn; J B de Boer; F G A van der Meché; J Passchier; R Q Hintzen
Journal:  Acta Neurol Scand       Date:  2003-12       Impact factor: 3.209

View more
  10 in total

Review 1.  Psychiatric disorders in multiple sclerosis.

Authors:  Maddalena Sparaco; Luigi Lavorgna; Simona Bonavita
Journal:  J Neurol       Date:  2019-06-13       Impact factor: 4.849

Review 2.  Mental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder.

Authors:  Aaron P Turner; Kevin N Alschuler; Abbey J Hughes; Meghan Beier; Jodie K Haselkorn; Alicia P Sloan; Dawn M Ehde
Journal:  Curr Neurol Neurosci Rep       Date:  2016-12       Impact factor: 5.081

3.  Predictors of Mood Disorders in Parents With Multiple Sclerosis: The Role of Disability Level, Coping Techniques, and Perceived Social Support.

Authors:  Jessica Podda; Michele Messmer Uccelli; Andrea Tacchino; Ludovico Pedullà; Margherita Monti Bragadin; Mario Alberto Battaglia; Giampaolo Brichetto; Michela Ponzio
Journal:  Int J MS Care       Date:  2022-06-20

Review 4.  The manifestation of affective symptoms in multiple sclerosis and discussion of the currently available diagnostic assessment tools.

Authors:  Melanie Filser; Axel Buchner; Gereon Rudolf Fink; Stefan M Gold; Iris-Katharina Penner
Journal:  J Neurol       Date:  2022-09-21       Impact factor: 6.682

Review 5.  Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis.

Authors:  Giulia Menculini; Elena Chipi; Federico Paolini Paoletti; Lorenzo Gaetani; Pasquale Nigro; Simone Simoni; Andrea Mancini; Nicola Tambasco; Massimiliano Di Filippo; Alfonso Tortorella; Lucilla Parnetti
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

6.  Anxiety, emotional processing and depression in people with multiple sclerosis.

Authors:  Marie-Claire Gay; Catherine Bungener; Sarah Thomas; Pierre Vrignaud; Peter W Thomas; Roger Baker; Sébastien Montel; Olivier Heinzlef; Caroline Papeix; Rana Assouad; Michèle Montreuil
Journal:  BMC Neurol       Date:  2017-02-23       Impact factor: 2.474

7.  Psychiatric and physical comorbidities and pain in patients with multiple sclerosis.

Authors:  Rogier Scherder; Neeltje Kant; Evelien T Wolf; Bas Pijnenburg; Erik Ja Scherder
Journal:  J Pain Res       Date:  2018-02-13       Impact factor: 3.133

8.  Work difficulties in people with multiple sclerosis: The role of anxiety, depression and coping.

Authors:  Eea van Egmond; K van der Hiele; Dam van Gorp; P J Jongen; Jjl van der Klink; M F Reneman; Eac Beenakker; Jjj van Eijk; Stfm Frequin; K de Gans; B M van Geel; Ohh Gerlach; Gjd Hengstman; J P Mostert; Wim Verhagen; Ham Middelkoop; L H Visser
Journal:  Mult Scler J Exp Transl Clin       Date:  2022-09-04

9.  Vitamin D Supplementation and Mental Health in Multiple Sclerosis Patients: A Systematic Review.

Authors:  Dominika Głąbska; Aleksandra Kołota; Katarzyna Lachowicz; Dominika Skolmowska; Małgorzata Stachoń; Dominika Guzek
Journal:  Nutrients       Date:  2021-11-24       Impact factor: 5.717

Review 10.  A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications.

Authors:  Larissa Hauer; Julian Perneczky; Johann Sellner
Journal:  J Neurol       Date:  2020-07-27       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.